Chemerin is a novel adipokine that affects inflammation, insulin resistance, metabolic
syndrome, and cardiovascular diseases. Nonetheless, it is unclear whether chemerin is …

Background: Chemerin expression has been documented to be increased in patients with
heart failure (HF), animal models of myocardial fibrosis (MF), and proliferation of cardiac …

Aims: Chemerin is a novel adipokine that is closely associated with cardiovascular diseases
and glucose homeostasis. This study aimed to investigate the effects of chemerin on insulin …

Aldosterone plays a pivotal role in the pathogenesis of metabolic syndrome and
cardiovascular disease; however, the underlying mechanisms have not been clarified …

Background: The adipokine chemerin has been associated with cardiovascular disease. We
investigated the effects of chemerin on viability and intracellular signalling in murine …

Since chemerin is an adipocytokine whose concentration in blood increases in the subjects
with various cardiac diseases, chemerin may be involved in pathogenesis of cardiac …

Background: Obesity-induced hypertension (OIH) has a high morbidity and mortality, and its
prevention and treatment has been a major challenge in clinical practice. Chemerin is a …

OBJECTIVE Chemerin is an adipokine that affects adipogenesis and glucose homeostasis
in adipocytes and increases with BMI in humans. This study was aimed at investigating the …

Obesity in human is an alarming major public health crisis worldwide and insulin resistance
is a hallmark of it. The negative cross-talk between skeletal muscle and adipose tissue …

Chemerin and its receptor, chemokine-like receptor 1 (CmklR1), are associated with
chemotaxis, inflammation, and endothelial function, especially in metabolic syndrome …